All In MedTech

FDA Clearance Tracker · P920014-S021

THORATEC HEARTMATE XVE LVAS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 31, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 31, 2003

Approved

Time to decision

191 days

Received Apr 23, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P920014-S021
Device name
THORATEC HEARTMATE XVE LVAS
Applicant
Thoratec Corp
Applicant location
Pleasanton, CA
Received
Apr 23, 2003
Decided
Oct 31, 2003
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P920014

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE USE OF A NEW INFLOW VALVE ASSEMBLY DESIGN FOR THE THORATEC HEARTMATE XVE LVAS.

Source documents

Other decisions for Thoratec Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.